Cardiology - MedEd On The Go

1-16 of 53

Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
Cardiology
Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
- Juan Badimon, PhD, FAHA
MinuteCE®
Advancing Patient-Centered Care in PAH
1.00 credit 10 episodes
- H. James Ford, MD
- Martha Kingman, DNP, FNP-C
- Jean M. Elwing, MD
- Hilary M. DuBrock, MD
1.00 credit 10 episodes
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
MinuteCE®
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
1.00 program credit
- H. James Ford, MD
1.00 program credit
Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
MinuteCE®
Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
1.00 program credit
- Martha Kingman, DNP, FNP-C
1.00 program credit
Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
MinuteCE®
Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
1.00 program credit
- Jean M. Elwing, MD
1.00 program credit
Integrating Palliative Care in Pulmonary Hypertension
Integrating Palliative Care in Pulmonary Hypertension
MinuteCE®
Integrating Palliative Care in Pulmonary Hypertension
1.00 program credit
- Martha Kingman, DNP, FNP-C
1.00 program credit
Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
MinuteCE®
Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
1.00 program credit
- Hilary M. DuBrock, MD
1.00 program credit
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
MinuteCE®
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
1.00 program credit
- Hilary M. DuBrock, MD
1.00 program credit
What Challenges and Triumphs Do Patients Face While Living With PAH?
What Challenges and Triumphs Do Patients Face While Living With PAH?
MinuteCE®
What Challenges and Triumphs Do Patients Face While Living With PAH?
1.00 program credit
- H. James Ford, MD
1.00 program credit
PROMs in Clinical Practice: Impacting Treatment Decisions
PROMs in Clinical Practice: Impacting Treatment Decisions
MinuteCE®
PROMs in Clinical Practice: Impacting Treatment Decisions
1.00 program credit
- Jean M. Elwing, MD
1.00 program credit
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
MinuteCE®
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
1.00 program credit
- H. James Ford, MD
1.00 program credit
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
MinuteCE®
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
1.00 program credit
- H. James Ford, MD
1.00 program credit
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CE
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
1.00 credit
- C. Michael Gibson, MD, MS
- Roxana Mehran, MD, FSCAI
1.00 credit
MinuteCE®
Differentiating First-Line Treatment Selection: Combination Immunotherapy and Chemotherapy Regimens for Metastatic ESCC
0.75 credits 7 episodes
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 credits 7 episodes
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
0.75 program credits
- Jaffer Ajani, MD
0.75 program credits
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 program credits
- Harry Yoon, MD
0.75 program credits

Prev
1
2
3
4
Next

1/4